drugset / Trial / NCT00949130

Comparative Study of NXL103 Versus Linezolid in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

NCT00949130

Phase 2 Completed 180 enrolled Novexel Inc
RandomizedParallel-groupSingle-blindTreatment

Summary

The objective of this study is to evaluate the efficacy and safety of oral NXL103 vs. established treatment of acute bacterial infection in adults.

Timeline

Start
2009-11
Primary completion
2010-03
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Linezolid Other / unclassified Oral
Subject NXL103 Unknown Oral

Indications

No indication recorded.